Clinical trial
Seroprevalence of Zoonotic and Arboviral Emerging Infections in Exposed Agents from the City of Montpellier: a Transversal Study.
NCT06859619 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Seroprevalence of Zoonotic and Arboviral Emerging Infections in Exposed Agents from the City of Montpellier: a Transversal Study.
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 3, 2025
- Completion date
- October 3, 2025
- Enrollment
- 183 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brucellosis, chikungunya virus infection, crimean-congo haemorrhagic fever virus, dengue virus, hantaviral infection nos, hepatitis e, leishmaniasis, leptospirosis, lyme disease, psittacosis, q fever, rickettsiosis, tick-borne encephalitis, toscana virus, tularemia, usutu virus, west nile virus, zika virus